Health Outcomes Statistical Analysis Protocol Development
Design FDA-compliant statistical protocols for health outcomes studies
What You Can Do
Create comprehensive statistical analysis plans (SAPs) that meet regulatory standards for health outcomes research. You can generate protocol frameworks, validate statistical methods, calculate power requirements, and produce reproducible analysis workflows with full documentation for FDA submissions, clinical trials, and real-world evidence studies. The skill ensures your analyses are auditable, replicable, and compliant with ICH-GCP and regulatory guidance.
Features
Automatically creates comprehensive SAPs specifying primary/secondary endpoints, statistical methods, analysis populations, hypothesis frameworks, and success criteria aligned with regulatory standards.
Validates your study design and analytical approach against FDA, ICH-GCP, and international health authority guidelines to ensure submissibility and audit readiness.
Calculates required sample sizes and statistical power for your primary outcome using appropriate effect sizes, significance levels, and multiplicity corrections with sensitivity analysis.
Produces fully annotated R and Python scripts for primary, secondary, and sensitivity analyses that can be version-controlled, audited, and re-executed to verify results.
Documents missing data strategies, assumption violations, and pre-specified subgroup analyses to strengthen study credibility and demonstrate robustness to regulators.
Maps your protocol to reporting standards (CONSORT for RCTs, STROBE for observational studies) ensuring transparent, complete reporting aligned with publication norms.
Evaluates proposed statistical tests for appropriateness given study design, outcome type (continuous, binary, time-to-event), and data characteristics with assumption diagnostics.
Creates auditable records of protocol modifications with justification narratives and impact assessments for regulatory submissions and data safety monitoring boards.
Example Output
Statistical Analysis Plan Output
Primary Endpoint Specification:
- Outcome: Time to clinical improvement (days)
- Population: Intent-to-Treat (N=280)
- Test: Kaplan-Meier + Cox proportional hazards regression
- Significance: α=0.05 two-tailed
- Power: 90% to detect hazard ratio of 1.6
Analysis Code (R):
library(survival)
fit_km <- survfit(Surv(time_days, improved) ~ treatment, data=trial_data)
fit_cox <- coxph(Surv(time_days, improved) ~ treatment + age + baseline_severity,
data=trial_data)
print(summary(fit_cox))
Sensitivity Analyses:
- Multiple imputation (MCAR, MAR, MNAR scenarios) for 12% missing outcomes
- Per-protocol population analysis (80% adherence threshold)
- Landmark analysis at 4, 8, 12 weeks
Regulatory Alignment:
- ✓ FDA E9 Statistical Principles (ICH-GCP compliant)
- ✓ STROBE checklist items 12a-b (analysis methods)
- ✓ Missing data handled per FDA 2021 guidance
- ✓ Multiplicity controlled (no α inflation)
What's Included
- Statistical Analysis Plan Template: Pre-structured SAP document with sections for study populations, endpoint definitions, hypotheses, statistical methods, multiplicity adjustments, and missing data strategies.
- Regulatory Compliance Checklist: FDA/ICH-GCP compliance verification matrix highlighting requirements met, gaps identified, and remediation steps for regulatory submission readiness.
- Power Analysis Workbook: Interactive sample size calculations, power sensitivity analysis, and assumption justification narratives with supporting references.
- Reproducible Analysis Scripts: Production-ready R and Python code with inline comments, validation diagnostics, and version control guidance for audit trails.
- Reporting Standards Mapping: Cross-references between protocol sections and CONSORT/STROBE checklist items ensuring transparent, guideline-compliant reporting.
- Method Selection Guide: Decision framework and evidence-based justifications for choosing statistical tests, handling assumptions, and planning robustness checks.
Who It's For
- Biostatisticians designing regulatory-grade clinical studies
- Health outcomes researchers conducting real-world evidence analyses
- Clinical research coordinators and regulatory affairs specialists
- Pharmaceutical and medical device company statisticians
- Academic medical center researchers preparing FDA submissions
Best For
- Clinical trial statistical analysis planning
- Real-world evidence and observational study protocols
- Comparative effectiveness research design
- Regulatory submissions requiring statistical protocols
- Post-market surveillance and pharmacovigilance analysis
You might also like
You can systematically review research protocols against ethical frameworks, regulatory standards, and risk-benefit principles. This skill identifies compliance gaps, assesses risks to human or animal subjects, evaluates scientific merit against potential harms, and generates structured compliance reports that support institutional review board (IRB) decisions and regulatory submissions.
by hah23255
You'll design and optimize observational study protocols from conception through regulatory documentation. The skill guides you through identifying and quantifying confounders, selecting appropriate study designs (cohort, case-control, cross-sectional), implementing bias mitigation strategies, and generating publication-ready protocols that meet regulatory standards.
by hah23255
Design, validate, and refine clinical device trial protocols that meet FDA and ICH regulatory requirements. You'll receive detailed protocol structure, endpoint validation matrices, statistical power analysis, and enrollment strategy recommendations that accelerate patient recruitment while maintaining compliance.
by hah23255
You get expert guidance developing NSF-aligned healthcare research proposals from strategic positioning through final compliance. Claude analyzes your research concept against NSF priorities, structures a competitive narrative, justifies budget allocations, and ensures all compliance requirements (biosketch, data management plans, institutional review) are met. The result is a cohesive, review-ready proposal that increases your chances of NSF funding.
by hah23255
You structure clinical research manuscripts according to IMRaD (Introduction, Methods, Results, Discussion) standards required by peer-reviewed journals. This skill helps you draft sections from raw research notes, polish prose for academic clarity, enforce citation standards, and identify common submission issues before sending to journals. The result is a manuscript ready for peer review with minimal editor feedback.
by hah23255
You can systematically work through complex clinical ethical dilemmas using proven frameworks like the Four Principles approach, principlism, casuistry, and virtue ethics. The skill maps all stakeholders, identifies competing ethical obligations, and generates IRB-ready documentation that prepares you for ethics committee consultations. You'll receive structured analysis, conflict resolution pathways, and compliance recommendations tailored to your specific case.
by hah23255
Create fully-accredited continuing medical education programs with learning objectives, educational content, assessments, and evaluation materials that meet ACCME and ANCC standards. This skill automates compliance validation, ensures proper alignment between objectives and content, and generates all required accreditation documentation in minutes instead of weeks.
by hah23255
You can design, validate, and execute statistical analyses for health outcomes research, comparative effectiveness studies, and clinical trials with regulatory rigor. This skill guides you through study design validation, appropriate statistical method selection, data quality assessment, hypothesis testing, and results interpretation aligned with FDA, EMA, and ICH-GCP standards. You'll generate publication-ready analysis plans and ensure your findings meet scientific and regulatory requirements for peer review or submission.
by hah23255